Dashboard
Manage Tickers

VXRTVaxart, Inc.

Nasdaq vaxart.com


$ 0.69 $ -0.06 (-7.63 %)    

Tuesday, 25-Jun-2024 15:59:49 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 479.35 $ 5.42 (1.14 %)
DIA $ 391.06 $ -2.96 (-0.75 %)
SPY $ 544.78 $ 2.09 (0.39 %)
TLT $ 94.49 $ 0.16 (0.17 %)
GLD $ 214.55 $ -1.07 (-0.5 %)
$ 0.6902
$ 0.73
$ 0.00 x 0
$ 0.00 x 0
$ 0.68 - $ 0.73
$ 0.52 - $ 1.54
4,641,908
na
120M
$ -0.90
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-13-2024 03-31-2024 10-Q
2 03-14-2024 12-31-2023 10-K
3 11-02-2023 09-30-2023 10-Q
4 08-03-2023 06-30-2023 10-Q
5 05-04-2023 03-31-2023 10-Q
6 03-15-2023 12-31-2022 10-K
7 11-09-2022 09-30-2022 10-Q
8 08-08-2022 06-30-2022 10-Q
9 05-09-2022 03-31-2022 10-Q
10 02-24-2022 12-31-2021 10-K
11 11-04-2021 09-30-2021 10-Q
12 08-05-2021 06-30-2021 10-Q
13 05-06-2021 03-31-2021 10-Q
14 02-25-2021 12-31-2020 10-K
15 11-12-2020 09-30-2020 10-Q
16 08-06-2020 06-30-2020 10-Q
17 05-12-2020 03-31-2020 10-Q
18 03-19-2020 12-31-2019 10-K
19 11-12-2019 09-30-2019 10-Q
20 08-08-2019 06-30-2019 10-Q
21 05-09-2019 03-31-2019 10-Q
22 02-06-2019 12-31-2018 10-K
23 11-13-2018 09-30-2018 10-Q
24 08-10-2018 06-30-2018 10-Q
25 05-15-2018 03-31-2018 10-Q
26 02-06-2018 12-31-2017 10-Q
27 11-07-2017 09-30-2017 10-Q
28 09-01-2017 06-30-2017 10-K
29 05-08-2017 05-02-2017 10-Q
30 02-06-2017 12-31-2016 10-Q
31 11-08-2016 09-30-2016 10-Q
32 09-13-2016 06-30-2016 10-K
33 05-10-2016 03-31-2016 10-Q
34 02-08-2016 12-31-2015 10-Q
35 11-06-2015 09-30-2015 10-Q
36 09-11-2015 06-30-2015 10-K
37 05-08-2015 03-31-2015 10-Q
38 02-06-2015 12-31-2014 10-Q
39 11-07-2014 09-30-2014 10-Q
40 09-30-2014 06-30-2014 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

1m-bet-on-this-penny-stock-check-out-these-4-stocks-under-2-insiders-are-aggressively-buying
$1M Bet On This Penny Stock? Check Out The...
06/21/2024 12:22:05

12-health-care-stocks-moving-in-wednesdays-intraday-session
12 Health Care Stocks Moving In Wednesday'...
06/19/2024 16:30:59

12-health-care-stocks-moving-in-tuesdays-intraday-session
12 Health Care Stocks Moving In Tuesday's ...
06/18/2024 16:31:11

vaxart-stock-is-moving-higher-after-the-bell-whats-going-on
Vaxart Stock Is Moving Higher After The Be...
06/17/2024 20:32:16

Vaxart, a clinical-stage biotechnology company developing a range of oral recombinant vaccines, announced Monday that proceeds ...

vaxart-provides-business-update-expects-net-proceeds-from-40m-offering-and-reimbursment-under-project-nextgen-award-of-up-to-453m-to-extend-cash-runaway-into-2026
Vaxart Provides Business Update; Expects N...
06/17/2024 20:08:10

— Cash runway extended into 2026 — — Received one of the largest BARDA-funded Project NextGen Awards to date, up to $453 millio...

vaxart-bags-453m-worth-barda-funded-project-seeks-to-raise-40m-via-equity-offering
Vaxart Bags $453M Worth BARDA-Funded Proje...
06/14/2024 14:06:12

Vaxart (VXRT) shares surged 23% in premarket session after receiving a $453 million project award from BARDA to conduct a COVID...

why-adobe-shares-are-trading-higher-by-around-15-here-are-20-stocks-moving-premarket
Why Adobe Shares Are Trading Higher By Aro...
06/14/2024 12:19:25

vaxart-shares-are-trading-higher-after-the-company-received-a-barda-funded-project-nextgen-award-valued-up-to-453-million-to-conduct-a-phase-2b-study-evaluating-its-covid-19-oral-pill-vaccine-candidate
Vaxart shares are trading higher after the...
06/14/2024 11:24:47

reported-earlier-vaxart-launches-40m-underwritten-offering-of-50m-common-stock-at-080share
Reported Earlier, Vaxart Launches $40M Und...
06/14/2024 06:50:03

Gross proceeds to Vaxart from the offering are expected to be $40 million, before deducting underwriting discounts and commissi...

12-health-care-stocks-moving-in-thursdays-after-market-session
12 Health Care Stocks Moving In Thursday's...
06/13/2024 20:31:04

vaxart-receives-up-to-453m-award-from-barda-for-phase-2b-study-of-oral-covid-19-vaccine
Vaxart Receives Up To $453M Award From BAR...
06/13/2024 20:16:20

Initial $65.7M For Study Start-Up; Remaining $387.2M Pending Further Study Approval; Enrollment Expected Summer 2024, Interim A...

palo-alto-networks-shares-drop-after-q3-results-in-line-guidance-the-details
Palo Alto Networks Shares Drop After Q3 Re...
05/20/2024 20:20:02

Palo Alto Networks reported quarterly earnings of $1.32 per share which beat the analyst consensus estimate of $1.25 by 5.6%. Q...

12-health-care-stocks-moving-in-tuesdays-pre-market-session
12 Health Care Stocks Moving In Tuesday's ...
05/14/2024 12:06:42

12-health-care-stocks-moving-in-mondays-after-market-session
12 Health Care Stocks Moving In Monday's A...
05/13/2024 20:31:07

vaxart-stock-climbs-after-blockbuster-q1-revenue
Vaxart Stock Climbs After Blockbuster Q1 R...
05/13/2024 20:29:57

Vaxart reported quarterly losses of 14 cents per share, inline with the analyst consensus estimate. Quarterly sales clocked in ...

vaxart-to-meet-with-fda-in-mid-2024-to-evaluate-clinical-data-and-discuss-next-steps-for-its-norovirus-program-anticipates-cash-runway-into-late-q4-of-2024
Vaxart To Meet With FDA In Mid-2024 To Eva...
05/13/2024 20:14:22

These data will inform potential next steps, such as potentially conducting a Phase 2b study and potentially a GII.4 challenge ...

vaxart-q1-2024-gaap-eps-014-inline-sales-2181m-beat-800000k-estimate
Vaxart Q1 2024 GAAP EPS $(0.14), Inline, S...
05/13/2024 20:11:16

Vaxart (NASDAQ:VXRT) reported quarterly losses of $(0.14) per share which met the analyst consensus estimate. The company repo...

12-health-care-stocks-moving-in-fridays-after-market-session
12 Health Care Stocks Moving In Friday's A...
05/10/2024 20:31:10

vaxart-announces-results-for-its-bivalent-norovirus-vaccine-candidate-in-lactating-mothers-long-term-goal-is-to-provide-protection-to-infants-through-passive-antibody-transfer
Vaxart Announces Results for Its Bivalent ...
04/30/2024 12:27:48

Antibody rise observed in lactating mothers and in their breast milk Long-term goal is to provide protection to infants through...

recap-vaxart-q4-earnings
Recap: Vaxart Q4 Earnings
03/14/2024 20:20:17

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION